Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Standardized extract of ginger ameliorates liver cancer by reducing proliferation and inducing apoptosis through inhibition oxidative stress/inflammation pathway
Alaaeldin Ahmed Hamza et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Efficacy and safety of apatinib alone or apatinib plus paclitaxel/docetaxel versus paclitaxel/docetaxel in the treatment of advanced non-small cell lung cancer: A meta-analysis
Zhe Li et al.
THORACIC CANCER (2021)
Anti-Angiogenic Therapy: Current Challenges and Future Perspectives
Filipa Lopes-Coelho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
P86.09 A Single-Arm Phase II Study of Anlotinib Combined with Pemetrexed plus Cisplatin as a First-Line Therapy in Advanced NSCLC
J. Xiong et al.
Journal of Thoracic Oncology (2021)
Anlotinib plus pemetrexed as a further treatment for patients with platinum-resistant ovarian cancer: A single-arm, open-label, phase II study.
Jueming Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Apatinib is effective as third-line and more treatment of advanced metastatic non-small-cell lung cancer A retrospective analysis in a real-world setting
Jiao Leng et al.
MEDICINE (2019)
The effect of apatinib combined with chemotherapy or targeted therapy on non-small cell lung cancer in vitro and vivo
Mingtao Liu et al.
THORACIC CANCER (2019)
Apatinib in the treatment of advanced non-small-cell lung cancer: A meta-analysis
Guo-Can Yu et al.
MATHEMATICAL BIOSCIENCES AND ENGINEERING (2019)
Apatinib monotherapy for advanced non-small cell lung cancer after the failure of chemotherapy or other targeted therapy
Zui Liu et al.
THORACIC CANCER (2018)
Development of a therapeutic model of precancerous liver using crocin-coated magnetite nanoparticles
Rkia El-Kharrag et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S. Novello et al.
ANNALS OF ONCOLOGY (2016)
Expression of cyclooxygenase 2 and vascular endothelial growth factor in gastric carcinoma: Relationship with clinicopathological parameters
Nesreen H. Hafez et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2016)
Slit2 Promotes Angiogenic Activity Via the Robo1-VEGFR2-ERK1/2 Pathway in Both In Vivo and In Vitro Studies
Shanshan Li et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Fibroblast Growth Factor Signaling Affects Vascular Outgrowth and Is Required for the Maintenance of Blood Vessel Integrity
Frederik De Smet et al.
CHEMISTRY & BIOLOGY (2014)
Establishing the Diagnosis of Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
M. Patricia Rivera et al.
CHEST (2013)
SLIT3-ROBO4 activation promotes vascular network formation in human engineered tissue and angiogenesis in vivo
Jonathan D. Paul et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation
Makoto Hayashi et al.
NATURE COMMUNICATIONS (2013)
Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population cells and ABCB1-overexpressing leukemia cells
Xiu-zhen Tong et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Texture analysis of liver fibrosis microscopic images: a study on the effect of biomarkers
Amr Amin et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2011)
Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2
Ni Zhu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies
Jin Li et al.
BMC CANCER (2010)
Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters
Yan-jun Mi et al.
CANCER RESEARCH (2010)
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
Suphansa Sawamiphak et al.
NATURE (2010)
The Control of Vascular Integrity by Endothelial Cell Junctions: Molecular Basis and Pathological Implications
Elisabetta Dejana et al.
DEVELOPMENTAL CELL (2009)
Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries
Arndt F. Siekmann et al.
NATURE (2007)
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Irene Noguera-Troise et al.
NATURE (2006)
Distinct genetic interactions between multiple Vegf receptors are required for development of different blood vessel types in zebrafish
LD Covassin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Dissection of angiogenic signaling in zebrafish using a chemical genetic approach
J Chan et al.
CANCER CELL (2002)
Share Paper
